Search

everythinglearnresearchcommunity

for

Search:↓

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Certain Dibenzo derivatives may help treat prostate cancer.

No significant link between CAG repeat numbers and female pattern hair loss in Han Chinese population.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Clascoterone may be an effective topical treatment for hair loss.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Parsley contains compounds that might be good for treating hair loss.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

New compounds were made that are promising for prostate cancer therapy.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Scopolin and scopoletin from Merremia peltata leaves may help treat hair loss and showed promising results in rabbit tests.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

No clear link between specific gene and hair loss in Mexican brothers.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Understanding androgen receptors, oxidative stress, and inflammation is key to developing better skin disease treatments.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.